Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
September 30, 2026 33.77M
June 30, 2026 28.59M
March 31, 2026 23.02M
December 31, 2025 26.88M
September 30, 2025 29.81M
June 30, 2025 36.92M
March 31, 2025 44.82M
December 31, 2024 46.18M
September 30, 2024 49.93M
June 30, 2024 49.23M
March 31, 2024 52.25M
December 31, 2023 54.81M
September 30, 2023 66.92M
June 30, 2023 87.00M
March 31, 2023 104.17M
December 31, 2022 113.32M
September 30, 2022 111.73M
June 30, 2022 115.19M
March 31, 2022 101.61M
December 31, 2021 90.62M
September 30, 2021 80.25M
June 30, 2021 57.49M
Date Value
March 31, 2021 45.49M
December 31, 2020 35.97M
September 30, 2020 24.14M
June 30, 2020 14.18M
March 31, 2020 10.11M
June 30, 2019 7.025M
March 31, 2019 4.914M
December 31, 2018 5.305M
September 30, 2018 4.198M
June 30, 2018 2.943M
March 31, 2018 2.168M
December 31, 2017 0.9917M
September 30, 2017 1.095M
June 30, 2017 1.294M
March 31, 2017 1.723M
December 31, 2016 1.841M
September 30, 2016 3.705M
June 30, 2016 6.207M
March 31, 2016 8.458M
December 31, 2015 10.12M
September 30, 2015 10.10M
June 30, 2015 7.95M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Talphera, Inc. 7.09M
Journey Medical Corp. 0.259M
ANI Pharmaceuticals, Inc. 50.60M
Corcept Therapeutics, Inc. 241.72M
Veru, Inc. 11.76M